Abstract LB-236: M4-3-ML2, a novel glycoengineered humanized IgG1 antibody, targeting a membrane-proximal epitope of MCSP/CSPG4 exhibits potent ADCC inductionin vitroandin vivoanti-tumoral efficacy in disseminated melanoma models